en ENGLISH
eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Bieżący numer Archiwum Filmy Artykuły w druku O czasopiśmie Suplementy Rada naukowa Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Standardy etyczne i procedury
1/2021
vol. 123
 
Poleć ten artykuł:
Udostępnij:
więcej
 
 
streszczenie artykułu:
Artykuł oryginalny

Assessment of IL-10/IL-6 ratio in differential diagnosis of primary vitreoretinal lymphoma – a case series report

Weronika Szliwa
1
,
Wojciech Adamski
1
,
Dariusz Wawrzyniak
2
,
Ewa Mizera-Nyczak
3
,
Aldona Kaczmarek
4
,
Katarzyna Rolle
2
,
Andrzej Marszałek
3
,
Iwona Rospond-Kubiak
1

1.
Department of Ophtahlmology, Poznan University of Medical Sciences, Poland
2.
Department of Molecular Neurooncology, Institute of Bioorganic Chemistry, Polish Academy of Science in Poznan, Poland
3.
Department of Cancer Pathology and Prophylaxis, Greater Poland Cancer Centre, Poznan, Poland
4.
Flow Cytometry Laboratory, Greater Poland Cancer Centre, Poznan, Poland
KLINIKA OCZNA 2021, 123, 1: 30–34
Data publikacji online: 2021/03/31
Pełna treść artykułu
Pobierz cytowanie
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 


Aim of the study
To analyze the clinical applicability of interleukin 10 (IL-10) and interleukin 6 (IL-6) ratio assessment in intraocular fluids for the diagnosis of vitreoretinal lymphoma.

Material and methods
The data of the patients who underwent a diagnostic vitrectomy or anterior chamber fluid aspiration because of the clinical suspicion of vitreoretinal lymphoma at the Department of Ophthalmology, Poznan University of Medical Sciences (PUMS), between 2016 and 2019, were retrospectively reviewed. All patients underwent full ophthalmological examination including ultrasound prior to the surgery. Routine histopathology examination and flow cytometry were performed in obtained vitreous samples or aqueous humor aspirate as well as the evaluation of IL-6 and IL-10 ratio (IL-10 : IL-6) with the ELISA assay.

Results
There were 7 patients: 3 women, 4 men in the mean age of 67 years (range: 60-81 years). In 2 cases, primary vitreous involvement was suspected, and in another 5, secondary. In 4 cases DLBCL (diffuse large B-cell lymphoma) was diagnosed. In 4 patients, the IL-10/IL-6 ratio was above 1.0, in 3 others - below 1.0. The median follow-up was 23 months (range: 2-82 months). 5 lymphoma patients died 13 months after ophthalmic diagnosis due to disease progression.

Conclusions
The assessment of IL-10 and IL-6 ratio may be a valuable tool facilitating the diagnosis of vitreoretinal lymphoma in some patients.

facebook linkedin twitter
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe